RedHill Biopharma (RDHL)
NASDAQ:RDHL
Holding RDHL?
Track your performance easily

RedHill Biopharma (RDHL) Income Statement

817 Followers

RedHill Biopharma Income Statement

Last quarter (Q ), RedHill Biopharma's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, RedHill Biopharma's net income was $―. See RedHill Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 35.90M$ 6.53M$ 61.80M$ 85.76M$ 64.36M$ 6.29M
Cost of Revenue
$ 18.45M$ 3.46M$ -33.34M$ -49.41M$ 36.89M$ 2.26M
Gross Profit
$ 17.45M$ 3.07M$ 28.46M$ 36.35M$ 27.47M$ 4.03M
Operating Expense
$ 33.72M$ 34.50M$ 113.69M$ 134.15M$ 91.15M$ 47.23M
Operating Income
$ -16.27M$ -31.43M$ -85.23M$ -97.80M$ -63.68M$ -43.20M
Net Non Operating Interest Income Expense
$ -31.14M$ 16.97M$ 13.56M$ 51.00K$ -12.57M$ 5.00K
Other Income Expense
-$ -38.49M$ -5.67M-$ 85.00K$ 892.00K
Pretax Income
$ -47.41M$ 23.92M$ -71.67M$ -97.74M$ -76.17M$ -42.30M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -47.41M$ 23.92M$ -71.67M$ -97.74M$ -76.17M$ -42.30M
Basic EPS
-$ 0.01$ 0.12$ 0.21--
Diluted EPS
-$ 0.01$ 0.12$ 0.21--
Basic Average Shares
-$ 2.59B$ 619.30M$ 465.27M--
Diluted Average Shares
-$ 2.59B$ 597.24M$ 465.45M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 52.16M$ 37.96M$ 80.36M$ 84.74M$ 128.04M$ 49.49M
Net Income From Continuing And Discontinued Operation
$ -47.41M$ 23.92M$ -71.67M$ -97.74M$ -76.17M$ -42.30M
Normalized Income
$ -47.41M$ 17.58M--$ -76.26M$ -43.20M
Interest Expense
$ 36.00M---$ 12.45M$ 390.00K
EBIT
$ -11.41M$ 24.28M$ -71.67M$ -97.74M$ -63.72M$ -41.91M
EBITDA
$ -7.41M$ 26.27M$ -69.53M$ -95.83M$ -54.98M$ -40.70M
Currency in USD

RedHill Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis